carbachol has been researched along with Pneumoconiosis in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Pneumoconiosis: A diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouhuys, A | 1 |
| Hunt, VR | 1 |
| Kim, BM | 1 |
| Zapletal, A | 1 |
1 other study available for carbachol and Pneumoconiosis
| Article | Year |
|---|---|
Maximum expiratory flow rates in induced bronchoconstriction in man.
Topics: Acetylcholine; Adult; Aerosols; Bronchi; Bronchodilator Agents; Carbachol; Constriction; Dilatation; | 1969 |